Spire Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.2K | Sell |
4,544
-700
| -13% | -$11.7K | ﹤0.01% | 1074 |
|
|
2025
Q1 | $80.6K | Buy |
5,244
+250
| +5% | +$3.84K | ﹤0.01% | 1118 |
|
|
2024
Q4 | $110K | Hold |
4,994
| – | – | ﹤0.01% | 1001 |
|
|
2024
Q3 | $90K | Sell |
4,994
-300
| -6% | -$5.41K | ﹤0.01% | 939 |
|
|
2024
Q2 | $86K | Sell |
5,294
-370
| -7% | -$6.01K | ﹤0.01% | 940 |
|
|
2024
Q1 | $79.9K | Hold |
5,664
| – | – | ﹤0.01% | 1060 |
|
|
2023
Q4 | $63.3K | Buy |
5,664
+80
| +1% | +$894 | ﹤0.01% | 1124 |
|
|
2023
Q3 | $57K | Hold |
5,584
| – | – | ﹤0.01% | 1128 |
|
|
2023
Q2 | $42K | Buy |
5,584
+1,375
| +33% | +$10.4K | ﹤0.01% | 1268 |
|
|
2023
Q1 | $37.3K | Buy |
4,209
+1,400
| +50% | +$12.4K | ﹤0.01% | 1331 |
|
|
2022
Q4 | $26K | Sell |
2,809
-2,058
| -42% | -$19K | ﹤0.01% | 1264 |
|
|
2022
Q3 | $39K | Sell |
4,867
-2,500
| -34% | -$20K | ﹤0.01% | 1051 |
|
|
2022
Q2 | $55K | Sell |
7,367
-5,970
| -45% | -$44.6K | ﹤0.01% | 1255 |
|
|
2022
Q1 | $125K | Sell |
13,337
-2,280
| -15% | -$21.4K | ﹤0.01% | 1089 |
|
|
2021
Q4 | $125K | Sell |
15,617
-133
| -0.8% | -$1.07K | ﹤0.01% | 1311 |
|
|
2021
Q3 | $153K | Buy |
15,750
+60
| +0.4% | +$583 | ﹤0.01% | 1022 |
|
|
2021
Q2 | $155K | Sell |
15,690
-5,622
| -26% | -$55.5K | ﹤0.01% | 1029 |
|
|
2021
Q1 | $246K | Buy |
+21,312
| New | +$246K | 0.01% | 969 |
|